2023 State of Clinical Trial Site Enablement Technology Report
Read this report to learn the 2023 trends and insights behind the state of technology powering the site and sponsor relationship.
Read Flipbook
Decentralized Trials
-
-
Investment in Site Enablement to Accelerate Research Grows 300% – Florence Healthcare Releases State of Clinical Trial Technology Report
ATLANTA - January 11, 2023 - Florence Healthcare™, a clinical research technology company, has released its annual State of Clinical Trial Technology Report. Over four hundred clinical research...
Read Blog
-
Real-world Evidence, How Integrated Tech Makes Things Happen
Watch Video
-
From Traditional to Digital Site Collaboration
Watch Video
-
Improving Patient Retention in Clinical Trials
Patient retention in clinical trials is one of the largest challenges facing sites, sponsors, and CROs. The Center for Information and Study on Clinical Research Participation found that 23% of...
Read Blog
-
Sites, DCTs, and Agile Trials... How Do They All Mix?
Watch Video
-
Emerging Business Models in Clinical Research as a Result of Technology Innovation
Watch Video
-
How Can Sites Collaborate with Sponsors to Increase Access to Clinical Trials
Watch Video
-
Research Revolution Conference, Powered by Florence Healthcare, Tackles Slowdown in Drug Development Due to Trial Site Stress
ATLANTA – November 8, 2022 – Research Revolution, a clinical trials conference organized by Florence Healthcare, welcomed more than 300 people to Atlanta, Georgia, November 1-3. During those three...
Read Blog
-
Supporting Ukraine Clinical Trials During a Time of War
Ukraine clinical trials continue to suffer because of Russia’s invasion. When the war began, clinical trial activity had to be frozen. While some trials have resumed and some international trials...
Read Blog
-
Medicaid coverage of clinical trials will improve inclusion: but there’s more work to do
On Jan. 1, 2022, the Clinical Trial Treatment Act went into effect, requiring all U.S. states and territories to cover routine clinical trial costs for Medicaid patients. Medicaid coverage of...
Read Blog
-
The role of clinical trial technology in creating and managing frontier sites
Historically, clinical trials have been concentrated at academic medical centers, large hospitals, and cancer centers. But under this approach, trials aren’t as inclusive or accessible as they...
Read Blog
-
5 Facts You Should Know About Patient-facing Technology
Patient-facing technology can make trials more accessible and help trials fit into participants’ lives. But if we’re not careful, technology built to empower patients may end up overwhelming them...
Read Blog
-
How Community Sites Can Improve the Lack of Diversity in Clinical Trials
The lack of diversity in clinical trials is one of the most pressing concerns confronting the clinical research industry. The recent FDA guidance for diversity in clinical trials calls on all...
Read Blog
-
How “frontier sites” and hybrid clinical trials can help research sites
The number of clinical trials has increased rapidly since 2020. 2021 saw a 14% increase in trial starts over 2020 and a 19% increase over 2019. And while 2020 was far from a typical year, the...
Read Blog
-
How Sponsors & CROs can start-up and collaborate with “frontier” sites
Watch Video
-
Technology Can Help Sites and Sponsors Prepare for the Rapid Growth of Clinical Trials
The number of new clinical trials is expected to increase 5.8% each year from 2022 to 2030. But research sites already struggle to keep up with trial workloads. With 1,015 new trials starting in...
Read Blog
-
How to Reduce Operational Costs of Clinical Trials in Uncertain Economic Conditions
Clinical trials can’t avoid fluctuating economic conditions. Changes in the market can especially impact emerging and early-stage biotech companies with limited cash reserves. A clinical trial's...
Read Blog
-
Remotely Manage Document Workflows with SiteLink
Read Flipbook
-
Breaking Down the FDA's 2022 Guidance on Diversity
Learn from Catherine Gregor about the newly published FDA draft guidance for increasing participant enrollment from underrepresented racial and ethnic groups in clinical trials.
Watch Video
-
Loading More...
